Jinhe Biotechnology: The impact of the US-Iran conflict on the company's overseas market is minimal.

Jinhe Biotechnology stated on the interactive platform on March 3 that the impact of the US-Iran conflict on the company's overseas market is minimal. The company's main overseas markets for pharmaceutical products are countries and regions such as the United States, Canada, South America, Europe, and Southeast Asia.